- Home
- VTYX vs FLXS Comparison
VTYX vs FLXS Comparison
Compare VTYX & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- FLXS
- Stock Information
- Founded
- VTYX 2018
- FLXS 2001
- Country
- VTYX United States
- FLXS United States
- Employees
- VTYX N/A
- FLXS N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- FLXS Home Furnishings
- Sector
- VTYX Health Care
- FLXS Consumer Discretionary
- Exchange
- VTYX Nasdaq
- FLXS Nasdaq
- Market Cap
- VTYX 154.9M
- FLXS 173.4M
- IPO Year
- VTYX 2021
- FLXS N/A
- Fundamental
- Price
- VTYX $1.27
- FLXS $32.79
- Analyst Decision
- VTYX Buy
- FLXS
- Analyst Count
- VTYX 4
- FLXS 0
- Target Price
- VTYX $11.33
- FLXS N/A
- AVG Volume (30 Days)
- VTYX 1.3M
- FLXS 20.8K
- Earning Date
- VTYX 05-08-2025
- FLXS 04-21-2025
- Dividend Yield
- VTYX N/A
- FLXS 2.07%
- EPS Growth
- VTYX N/A
- FLXS N/A
- EPS
- VTYX N/A
- FLXS 2.55
- Revenue
- VTYX N/A
- FLXS $437,284,000.00
- Revenue This Year
- VTYX N/A
- FLXS $8.34
- Revenue Next Year
- VTYX N/A
- FLXS $4.01
- P/E Ratio
- VTYX N/A
- FLXS $12.85
- Revenue Growth
- VTYX N/A
- FLXS 7.24
- 52 Week Low
- VTYX $0.78
- FLXS $28.81
- 52 Week High
- VTYX $5.66
- FLXS $65.87
- Technical
- Relative Strength Index (RSI)
- VTYX 56.45
- FLXS 40.43
- Support Level
- VTYX $1.14
- FLXS $31.94
- Resistance Level
- VTYX $1.32
- FLXS $33.22
- Average True Range (ATR)
- VTYX 0.09
- FLXS 1.87
- MACD
- VTYX 0.04
- FLXS 0.28
- Stochastic Oscillator
- VTYX 90.22
- FLXS 30.93
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.